| Literature DB >> 23576857 |
Felicitas Escher1, Mario Kasner, Uwe Kühl, Johannes Heymer, Ursula Wilkenshoff, Carsten Tschöpe, Heinz-Peter Schultheiss.
Abstract
BACKGROUND: The diagnosis of acute myocarditis (AMC) and inflammatory cardiomyopathy (DCMi) can be difficult. Speckle tracking echocardiography with accurate assessments of regional contractility could have an outstanding importance for the diagnosis. METHODS ANDEntities:
Mesh:
Year: 2013 PMID: 23576857 PMCID: PMC3616345 DOI: 10.1155/2013/875420
Source DB: PubMed Journal: Mediators Inflamm ISSN: 0962-9351 Impact factor: 4.711
Clinical characteristics.
| Parameter | Acute myocarditis | Patients without | Patients with inflammation at followup |
|---|---|---|---|
| Gender (m/f), | 17/8 | 11/6 | 5/3 |
| Age, y | 41.3 ± 12.5 | 40.4 ± 11.5 | 43.5 ± 14.7 |
| BMI, kg/m² | 27.0 ± 3.3 | 26.7 ± 3.5 | 27.1 ± 3.4 |
| Arrhythmias, | 8 | 1 | 4 |
| (i) Atrial fibrillation/flutter | 6 | 1 | 2 |
| (ii) Ventricular tachycardia | 1 | 0 | 0 |
| (iii) Bradycardia | 0 | 0 | 0 |
| Atrial ventricular block, | 0 | 0 | 0 |
| Left bundle branch block, | 0 | 0 | 0 |
| Hypertension, | 7 | 5 | 2 |
| Hyperlipidaemia, | 4 | 2 | 2 |
| Diabetes mellitus, | 1 | 1 | 0 |
|
| 19 | 8 | 4 |
| ACE inhibitors, | 21 | 4 | 4 |
| Statins, | 4 | 2 | 2 |
Data were not significant between patients with and without inflammation at followup. Data are shown as mean ± standard deviation.
BMI: body mass index; ACE: angiotensin converting enzyme.
Figure 3Representative images of EMBs: (a) HE staining of samples from patients with acute myocarditis at baseline, (b) immunohistochemical staining of extremely increased CD3 positive T-lymphocytes in acute myocarditis at baseline, (c) immunohistochemical staining of CD3 positive T-lymphocytes in patients without inflammation at followup, and (d) increased CD3 positive T-lymphocytes in patients with proof of inflammation at followup (magnification 200×).
Figure 4Representative strain imaging by speckle tracking imaging in (a) patients with inflammation in EMB specimens at followup in a 4-chamber view, (b) 2-chamber view, (c) patients without EMB inflammation in a 4-chamber view, (d) 2-chamber view.
Intramyocardial inflammation by immunohistochemistry and virus genomes by PCR.
| Parameter | Acute myocarditis at baseline | Patients without Inflammation at followup | Patients with Inflammation at followup |
|---|---|---|---|
| Inflammation | |||
| CD3+/mm2 | 45.0 ± 17.0 | 4.9 ± 2.1 | 20.5 ± 5.4* |
| LFA-1+/mm2 | 57.7 ± 25.6 | 3.3 ± 7.1 | 29.3 ± 7.1* |
| Mac-1+/mm2 | 95.5 ± 44.8 | 19.8 ± 10.4 | 28.8 ± 13.2 |
| HLA class I/AF | 0.082 ± 0.068 | 0.045 ± 0.015 | 0.057 ± 0.009 |
| ICAM-1/AF | 0.051 ± 0.042 | 0.023 ± 0.017 | 0.033 ± 0.0137 |
| Virus | |||
| Enterovirus, | 2 | 0 | 1 |
| B19, | 17 | 9 | 10 |
| HHV-6, | 1 | 1 | 0 |
*Significant differences between patients with and without inflammation at followup. ns: not significant. Data are shown as mean ± standard deviation.
Conventional echocardiographic parameters and speckle tracking echocardiography at baseline and at followup.
| Parameter | Acute myocarditis | Patients without inflammation | Patients with inflammation |
|---|---|---|---|
| LVEF, % | 40.4 ± 10.3 | 65.3 ± 6.1 | 56.2 ± 7.2* |
| Regional wall abnormalities, | 10 | 2 | 2 |
| LVEDD, mm | 59 ± 8 | 51 ± 3 | 55 ± 4 |
| LVESD, mm | 51 ± 7 | 39 ± 5 | 42 ± 7 |
| LA, mL | 35.4 ± 5.4 | 34.6 ± 4.2 | 37.8 ± 6.3 |
| Septum, mm | 13.1 ± 0.4 | 10.4 ± 0.5 | 11.5 ± 1.4 |
| Posterior wall, mm | 11.2 ± 1.7 | 11.2 ± 0.5 | 10.2 ± 0.8 |
| Dispersing wall, | 16 | 3 | 3 |
| LV mass index, g/m² | 91.1 ± 18.4 | 76.3 ± 10.1 | 86.2 ± 11.1* |
| FS, % | 19.3 ± 4.2 | 32.1 ± 7.1 | 21.5 ± 6.0* |
| LSR, 1/s | 0.53 ± 0.29 | 1.3 ± 0.3 | 0.78 ± 0.4* |
| LS, % | 8.36 ± 3.47 | 16.87 ± 2.0 | 9.4 ± 1.4* |
| LSRsep, 1/s | 0.54 ± 0.34 | 0.81 ± 0.41 | 0.51 ± 0.14* |
| LSsep, % | 12.98 ± 2.76 | 16.65 ± 3.98 | 13.43 ± 4.32* |
*Significant differences between patients with and without inflammation at followup. ns: not significant. Data are shown as mean ± standard deviation.
LVEDD: left ventricular enddiastolic diameter, LVESD: left ventricular endsystolic diameter, LA: left atrium, FS: fractional shortening, LSR: global systolic longitudinal strain rate, LSRsep: septal longitudinal systolic strain rate, LS: global systolic longitudinal strain, LSsep: septal systolic longitudinal strain.
Figure 1Quantitative analysis of global longitudinal strain (in %) in AMC at baseline and at followup in patients with inflammation (n = 8) in EMB and without inflammation (n = 17) at followup. Columns represent mean ± standard deviation with *P < 0.05.
Figure 2Analysis of global longitudinal strain (in %) correlated with inflammation in EMB. (a) Correlation between global longitudinal strain and CD3 positive T-lymphocytes. (b) Correlation between global longitudinal strain and LFA-1 positive lymphocytes. (c) Correlation between global longitudinal strain and Mac-1 positive cells used as marker for macrophages and (d) correlation between global longitudinal strain and HLA-1 expression.